| Price | 0.00 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | N/A - N/A |
| Open Price | $0.00 |
| Previous Close | $0.00 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $0.00 - $0.50 |
| Volume | 0 |
| Genta Incorporated is a biopharmaceutical company with a product portfolio focused on anticancer therapy, including its Anticode platform technology, as well as other important anticancer products. The company's lead compound, G3139, has received ``Fast Track'' designation from the Food and Drug Administration and has entered Phase 3 trials in patients with advanced melanoma. Genta aims to become a direct marketer of its drugs in the United States. (PRESS RELEASE) | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment